Israeli startup OncoHost announced today an upsized and oversubscribed $35 million Series C funding round, led by ALIVE Israel HealthTech VC, with the participation of Leumi Partners, Menora Mivtachim, OurCrowd and other existing investors.
Read more here.
The post [OncoHost in Forbes] $35 million in new funding for AI to personalize cancer treatment appeared first on OurCrowd Blog.
Go to Source of this post
Author Of this post: OurCrowd
Title Of post: [OncoHost in Forbes] $35 million in new funding for AI to personalize cancer treatment
Author Link: {authorlink}